Intradermal vaccination with hollow microneedles: A comparative study of various protein antigen and adjuvant encapsulated nanoparticles-Reference-Cited by-同舟云学术

Intradermal vaccination with hollow microneedles: A comparative study of various protein antigen and adjuvant encapsulated nanoparticles

Published:2017-11 Issue: Volume:266 Page:109-118
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Du Guangsheng^ORCID,Hathout Rania M.,Nasr Maha^ORCID,Nejadnik M. Reza,Tu Jing,Koning Roman I.,Koster Abraham J.,Slütter Bram^ORCID,Kros Alexander,Jiskoot Wim^ORCID,Bouwstra Joke A.,Mönkäre Juha

Funder

Innovative Medicines Initiative

Seventh Framework Programme

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference53 articles.

1. Transcutaneous vaccines: novel advances in technology and delivery for overcoming the barriers;Li;Vaccine,2011

2. Microneedle technologies for (trans)dermal drug and vaccine delivery;van der Maaden;J. Control. Release,2012

3. Improved piercing of microneedle arrays in dermatomed human skin by an impact insertion method;Verbaan;J. Control. Release,2008

4. Novel hollow microneedle technology for depth-controlled microinjection-mediated dermal vaccination: a study with polio vaccine in rats;van der Maaden;Pharm. Res. Dordr.,2014

5. Determination of depth-dependent intradermal immunogenicity of adjuvanted inactivated polio vaccine delivered by microinjections via hollow microneedles;Schipper;Pharm. Res.,2016

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent progress of microneedles in transdermal immunotherapy: A review;International Journal of Pharmaceutics;2024-09

2. Expanding the arsenal against diabetes mellitus via transdermal application of drug-loaded nanoparticles and microneedles: Recent advances and future perspectives;Journal of Drug Delivery Science and Technology;2024-09

3. Thermoresponsive nanosponges: Efficient antigen delivery carriers and adjuvants for in vivo vaccination;European Polymer Journal;2024-08

4. EP2/EP4 targeting prevents tumor-derived PGE2-mediated immunosuppression in cDC2s;Journal of Leukocyte Biology;2024-07-23

5. Phase 1, randomized, rater and participant blinded placebo-controlled study of the safety, reactogenicity, tolerability and immunogenicity of H1N1 influenza vaccine delivered by VX-103 (a MIMIX microneedle patch [MAP] system) in healthy adults;PLOS ONE;2024-06-06